It is estimated that in 2025 there will be a total of 226,650 new cases of lung and bronchus cancer in the United States. The highest number of these cases are estimated to be in the state of Florida. This statistic presents the estimated number of new lung and bronchus cancer cases in the United States in 2025, by state.

From 2018 to 2022, the overall death rate for lung and bronchus cancer in the United States was 38.7 per 100,000 for males and 27.6 per 100,000 for females. This statistic presents the death rates for lung and bronchus cancer in the United States from 2018 to 2022, by gender and race/ethnicity.

This dataset contains Cancer Incidence data for Lung Cancer (All Stages^) including: Age-Adjusted Rate, Confidence Interval, Average Annual Count, and Trend field information for US States for the average 5 year span from 2016 to 2020.Data are segmented by sex (Both Sexes, Male, and Female) and age (All Ages, Ages Under 50, Ages 50 & Over, Ages Under 65, and Ages 65 & Over), with field names and aliases describing the sex and age group tabulated.For more information, visit statecancerprofiles.cancer.govData NotationsState Cancer Registries may provide more current or more local data.TrendRising when 95% confidence interval of average annual percent change is above 0.Stable when 95% confidence interval of average annual percent change includes 0.Falling when 95% confidence interval of average annual percent change is below 0.† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.‡ Incidence Trend data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.Rates and trends are computed using different standards for malignancy. For more information see malignant.^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.Data Source Field Key(1) Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.(5) Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.(6) Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).(7) Source: SEER November 2022 submission.(8) Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with SEER November 2022 data.Some data are not available, see Data Not Available for combinations of geography, cancer site, age, and race/ethnicity.Data for the United States does not include data from Nevada.Data for the United States does not include Puerto Rico.

BackgroundAlthough strong exposure to arsenic has been shown to be carcinogenic, its contribution to lung cancer incidence in the United States is not well characterized. We sought to determine if the low-level exposures to arsenic seen in the U.S. are associated with lung cancer incidence after controlling for possible confounders, and to assess the interaction with smoking behavior. MethodologyMeasurements of arsenic stream sediment and soil concentration obtained from the USGS National Geochemical Survey were combined, respectively, with 2008 BRFSS estimates on smoking prevalence and 2000 U.S. Census county level income to determine the effects of these factors on lung cancer incidence, as estimated from respective state-wide cancer registries and the SEER database. Poisson regression was used to determine the association between each variable and age-adjusted county-level lung cancer incidence. ANOVA was used to assess interaction effects between covariates. Principal FindingsSediment levels of arsenic were significantly associated with an increase in incident cases of lung cancer (P

It is estimated that in 2025 there will be a total of ******* new cases of lung and bronchus cancer in the United States. In addition, it is predicted that there will be around ******* deaths from lung and bronchus cancer that year. This statistic presents the estimated number of new lung and bronchus cancer cases and deaths in the United States in 2025, by gender.

Information about the rates of cancer deaths in each state is reported. The data shows the total rate as well as rates based on sex, age, and race. Rates are also shown for three specific kinds of cancer: breast cancer, colorectal cancer, and lung cancer.

Original Data

Column Description

Key	List of...	Comment	Example Value
State	String	The name of a U.S. State (e.g., Virginia)	"Alabama"
Total.Rate	Float	Total Cancer Deaths (Rate per 100,000 Population, 2007-2013) 214.2	214.2
Total.Number	Float	Total Cancer Deaths (2007-2013)	71529.0
Total.Population	Float	Cumulative Population (Denominator Total_Cancer deaths total_) 2007-2013	33387205.0
Rates.Age.< 18	Float	Total Cancer Deaths (Under 18 Years, Rate per 100,000 Population, 2007-2013)	2.0
Rates.Age.18-45	Float	Total Cancer Deaths (18 to 44 Years, Rate per 100,000 Population, 2007-2013)	18.5
Rates.Age.45-64	Float	Total Cancer Deaths (45 to 64 Years, Rate per 100,000 Population, 2007-2013)	244.7
Rates.Age.> 64	Float	Total Cancer Deaths (65 Years and Over, Rate per 100,000 Population, 2007-2013)	1017.8
Rates.Age and Sex.Female.< 18	Float	Female under 18	2.0
Rates.Age and Sex.Male.< 18	Float	Male under 18	2.1
Rates.Age and Sex.Female.18 - 45	Float	Female 18 - 45	20.1
Rates.Age and Sex.Male.18 - 45	Float	Male 18 - 45	16.8
Rates.Age and Sex.Female.45 - 64	Float	Female 45 to 64 Years	201.0
Rates.Age and Sex.Male.45 - 64	Float	Male 45 to 64 Years	291.5
Rates.Age and Sex.Female.> 64	Float	Female 65 Years and Over	803.6
Rates.Age and Sex.Male.> 64	Float	Male 65 Years and Over	1308.6
Rates.Race.White	Float	Total Cancer Deaths (White, Rate per 100,000 Population, 2007-2013)	186.1
Rates.Race.White non-Hispanic	Float	Total Cancer Deaths (White non-Hispanic, Rate per 100,000 Population, 2007-2013)	187.5
Rates.Race.Black	Float	Total Cancer Deaths (Black or African American, Rate per 100,000 Population, 2007-2013)	216.1
Rates.Race.Asian	Float	Total Cancer Deaths (Asian or Pacific Islander, Rate per 100,000 Population, 2007-2013)	81.3
Rates.Race.Indigenous	Float	Total Cancer Deaths (American Indian or Alaska Native, Rate per 100,000 Population, 2007-2013)	69.9
Rates.Race and Sex.Female.White	Float	Female: White	149.2
Rates.Race and Sex.Female.White non-Hispanic	Float	Female: White non-Hispanic	150.2
Rates.Race and Sex.Female.Black	Float	Female: Black or African American	167.2
Rates.Race and Sex.Female.Black non-Hispanic	Float	Female: Black or African American non-Hispanic	167.9
Rates.Race and Sex.Female.Asian	Float	Female: Asian or Pacific Islander	84.9
Rates.Race and Sex.Female.Indigenous	Float	Female: American Indian or Alaska Native	53.8
...

Patient demographics of Indiana residents diagnosed with lung cancer (n = 110,935).

Population based cancer incidence rates were abstracted from National Cancer Institute, State Cancer Profiles for all available counties in the United States for which data were available. This is a national county-level database of cancer data that are collected by state public health surveillance systems. All-site cancer is defined as any type of cancer that is captured in the state registry data, though non-melanoma skin cancer is not included. All-site age-adjusted cancer incidence rates were abstracted separately for males and females. County-level annual age-adjusted all-site cancer incidence rates for years 2006–2010 were available for 2687 of 3142 (85.5%) counties in the U.S. Counties for which there are fewer than 16 reported cases in a specific area-sex-race category are suppressed to ensure confidentiality and stability of rate estimates; this accounted for 14 counties in our study. Two states, Kansas and Virginia, do not provide data because of state legislation and regulations which prohibit the release of county level data to outside entities. Data from Michigan does not include cases diagnosed in other states because data exchange agreements prohibit the release of data to third parties. Finally, state data is not available for three states, Minnesota, Ohio, and Washington. The age-adjusted average annual incidence rate for all counties was 453.7 per 100,000 persons. We selected 2006–2010 as it is subsequent in time to the EQI exposure data which was constructed to represent the years 2000–2005. We also gathered data for the three leading causes of cancer for males (lung, prostate, and colorectal) and females (lung, breast, and colorectal). The EQI was used as an exposure metric as an indicator of cumulative environmental exposures at the county-level representing the period 2000 to 2005. A complete description of the datasets used in the EQI are provided in Lobdell et al. and methods used for index construction are described by Messer et al. The EQI was developed for the period 2000– 2005 because it was the time period for which the most recent data were available when index construction was initiated. The EQI includes variables representing each of the environmental domains. The air domain includes 87 variables representing criteria and hazardous air pollutants. The water domain includes 80 variables representing overall water quality, general water contamination, recreational water quality, drinking water quality, atmospheric deposition, drought, and chemical contamination. The land domain includes 26 variables representing agriculture, pesticides, contaminants, facilities, and radon. The built domain includes 14 variables representing roads, highway/road safety, public transit behavior, business environment, and subsidized housing environment. The sociodemographic environment includes 12 variables representing socioeconomics and crime. This dataset is not publicly accessible because: EPA cannot release personally identifiable information regarding living individuals, according to the Privacy Act and the Freedom of Information Act (FOIA). This dataset contains information about human research subjects. Because there is potential to identify individual participants and disclose personal information, either alone or in combination with other datasets, individual level data are not appropriate to post for public access. Restricted access may be granted to authorized persons by contacting the party listed. It can be accessed through the following means: Human health data are not available publicly. EQI data are available at: https://edg.epa.gov/data/Public/ORD/NHEERL/EQI. Format: Data are stored as csv files. This dataset is associated with the following publication: Jagai, J., L. Messer, K. Rappazzo , C. Gray, S. Grabich , and D. Lobdell. County-level environmental quality and associations with cancer incidence#. Cancer. John Wiley & Sons Incorporated, New York, NY, USA, 123(15): 2901-2908, (2017).

This map shows the incidence rate per 100,000 of lung and bronchus cancer by county. Counties are shaded based on quartile distribution. The lighter shaded counties have lower incidence rates of lung and bronchus cancer. The darker shaded counties have higher incidence rates of lung and bronchus cancer. New York State Community Health Indicator Reports (CHIRS) were developed in 2012, and are updated annually to consolidate and improve data linkages for the health indicators included in the County Health Assessment Indicators (CHAI) for all communities in New York. The CHIRS present data for more than 300 health indicators that are organized by 15 different health topics. Data if provided for all 62 New York State counties, 8 regions (including New York City), the State excluding New York City, and New York State. For more information, check out: http://www.health.ny.gov/statistics/chac/indicators/. The "About" tab contains additional details concerning this dataset.

It is estimated that in 2024 there will be a total of 124,730 deaths due to lung and bronchus cancer in the United States. Florida is estimated to account for the highest number of these deaths. This statistic presents the estimated number of lung and bronchus cancer deaths in the United States in 2025, by state.

Summary statistics for lung cancer incidence rates in the Mid-South states, 1999–2012 (cases per 100,000).

This dataset contains estimates for 29 cancer-specific age-standardized mortality rates for specific cancer types at the county level for each state, the District of Columbia, and the United States as a whole for 1980-2014 (quinquennial), as well as the changes in rates during this period.

Indiana county-level characteristics (counties: n = 92).

This statistic shows the death rate of lung and bronchus cancer in the United States from 1999 to 2023. The maximum rate in the given period was **** per every 100,000 age-adjusted population in 2000. The minimum rate stood at **** in 2023.

Summary statistics of average lung cancer incidence rates and average daily smokers in percentage in 8 U.S. geographic regions, 1999–2012.

Summary statistics of lung cancer incidence rates for Whites in 8 U.S. geographic regions, 1999–2012 (cases per 100,000).

Incidence Rates Of Lung And Bronchial Cancer Per 100,000 All States

Death rate has been age-adjusted by the 2000 U.S. standard population. Single-year data are only available for Los Angeles County overall, Service Planning Areas, Supervisorial Districts, City of Los Angeles overall, and City of Los Angeles Council Districts.Lung cancer is a leading cause of cancer-related death in the US. People who smoke have the greatest risk of lung cancer, though lung cancer can also occur in people who have never smoked. Most cases are due to long-term tobacco smoking or exposure to secondhand tobacco smoke. Cities and communities can take an active role in curbing tobacco use and reducing lung cancer by adopting policies to regulate tobacco retail; reducing exposure to secondhand smoke in outdoor public spaces, such as parks, restaurants, or in multi-unit housing; and improving access to tobacco cessation programs and other preventive services.For more information about the Community Health Profiles Data Initiative, please see the initiative homepage.

Rate: Number of deaths due to cancer of the trachea, bronchus, and lung per 100,000 Population.

Definition: Number of deaths per 100,000 with malignant neoplasm (cancer) cancer of the trachea, bronchus, and lung as the underlying cause (ICD-10 codes: C33-C34).

Data Sources:

(1) Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File. CDC WONDER On-line Database accessed at http://wonder.cdc.gov/cmf-icd10.html

(2) Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health

(3) Population Estimates, State Data Center, New Jersey Department of Labor and Workforce Development

From 2017 to 2021, the overall incidence rate for lung and bronchus cancer in the United States was **** per 100,000 for males and **** per 100,000 for females. This statistic presents the incidence rates of lung and bronchus cancer in the United States from 2017 to 2021, by gender and race/ethnicity.